These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Early Phase I Study of a Xing Y; Chand G; Liu C; Cook GJR; O'Doherty J; Zhao L; Wong NCL; Meszaros LK; Ting HH; Zhao J J Nucl Med; 2019 Sep; 60(9):1213-1220. PubMed ID: 30796165 [TBL] [Abstract][Full Text] [Related]
5. Preclinical development and characterisation of Wong NC; Cai Y; Meszaros LK; Biersack HJ; Cook GJ; Ting HH; Mottaghy FM Am J Nucl Med Mol Imaging; 2021; 11(3):154-166. PubMed ID: 34234994 [TBL] [Abstract][Full Text] [Related]
6. Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy. Gao H; Wu Y; Shi J; Zhang X; Liu T; Hu B; Jia B; Wan Y; Liu Z; Wang F J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203663 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive Imaging of Tumor PD-L1 Expression Using [ Zhang Y; Ding Y; Li N; Wang S; Zhou S; Li R; Yang H; Li W; Qu J Mol Pharm; 2023 Jan; 20(1):690-700. PubMed ID: 36541699 [TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
9. Hu B; Chen W; Zhang Y; Shi H; Cheng D; Xiu Y Ann Nucl Med; 2020 May; 34(5):322-328. PubMed ID: 32130663 [TBL] [Abstract][Full Text] [Related]
10. Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8 Ertveldt T; Meulewaeter S; De Vlaeminck Y; Olarte O; Broos K; Van Calenbergh S; Bourgeois S; Deprez J; Heremans Y; Goyvaerts C; Staels W; De Smedt S; Dewitte H; Devoogdt N; Keyaerts M; Verbeke R; Barbé K; Lentacker I; Breckpot K Theranostics; 2023; 13(15):5483-5500. PubMed ID: 37908728 [No Abstract] [Full Text] [Related]
12. Retraction Note to: Inter- and intraobserver agreement of the quantitative assessment of [ Hughes DJ; Chand G; Goh V; Cook GJR EJNMMI Res; 2021 Oct; 11(1):102. PubMed ID: 34637006 [No Abstract] [Full Text] [Related]
13. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma. Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372 [TBL] [Abstract][Full Text] [Related]
15. Detection of cervical lymph node metastases of nasopharyngeal carcinomas with technetium-99m tetrofosmin single photon emission computed tomography and comparison with computed tomography. Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH Anticancer Res; 2001; 21(1B):723-6. PubMed ID: 11299833 [TBL] [Abstract][Full Text] [Related]
16. Coregistered ventilation and perfusion SPECT using krypton-81m and Tc-99m-labeled macroaggregated albumin with multislice CT utility for prediction of postoperative lung function in non-small cell lung cancer patients. Ohno Y; Koyama H; Takenaka D; Nogami M; Kotani Y; Nishimura Y; Yoshimura M; Yoshikawa T; Sugimura K Acad Radiol; 2007 Jul; 14(7):830-8. PubMed ID: 17574133 [TBL] [Abstract][Full Text] [Related]
17. Intra-individual comparison of Bénard F; Harsini S; Wilson D; Zukotynski K; Abikhzer G; Turcotte E; Cossette M; Metser U; Romsa J; Martin M; Mar C; Saad F; Soucy JP; Eigl BJ; Black P; Krauze A; Burrell S; Nichol A; Tardif JC Lancet Oncol; 2022 Dec; 23(12):1499-1507. PubMed ID: 36343655 [TBL] [Abstract][Full Text] [Related]
20. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis. Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]